Fig. 3From: Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance geneGlobal survival (OS) in patients with ALL treated with metformin (metformin users and metformin non-users). OS at 60 months in patients treated with metformin was analyzed, and no significant differences were found between the two groups (p = 0.251, 95% CI)Back to article page